The Karnataka government, in order to tide over a shortfall in Covaxin stock in the state, has directed health officials to administer the second dose of Covid-19 vaccine only to people aged above 45 years.
In an official order on Monday the state government said: “In order to tide over the current situation of short supply of Covaxin in the State of Karnataka, it is hereby advised that all the private health care institutions should utilize the available stock of Covaxin at their respective health facility, as the second dose for the age group 45 plus who are awaiting for the second dose of Covaxin as per the COVID vaccination schedule of Government of India.”
Karnataka recorded 25,311 fresh Covid-19 cases, 57,333 discharges and 529 deaths in the last 24 hours, as per the state health bulletin yesterday. The active cases in the state stand at 4,40,435.
The state is also witnessing a surge in black fungus cases. Karnataka has reported 446 cases of mucormycosis or black fungus infections and 12 related fatalities so far, the state’s Health and Medical Education Minister K Sudhakar said yesterday.
Following this, Union Minister for Chemicals and Fertilisers DV Sadananda Gowda announced that an additional 1,030 vials of Amphotericin-B, a drug used to treat black fungus, have been allocated to Karnataka. Gowda took to Twitter and informed about the allocation of drugs.
Three days ago, the Karnataka government extended the statewide lockdown to contain the spread of Covid-19 till 6 am on June 7.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.